亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

張家港保稅區(qū)凱利特化工有限公司  

原料藥,醫(yī)藥中間體,精細(xì)化學(xué)品

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人:姚廣
  • 電話:18252995085
  • QQ:524465307
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
吉非替尼
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 江蘇蘇州市付款后3天內(nèi)
品牌 吉非替尼184475-35-2
型號(hào) 184475-35-2
規(guī)格 吉非替尼184475-35-2
過(guò)期 長(zhǎng)期有效
更新 2012-08-30 13:43
 
詳細(xì)信息
產(chǎn)品名稱:吉非替尼184475-35-2
化學(xué)名:N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-嗎啉-4-丙氧基)喹唑啉-4-胺
英文名:Gefitinib
別名:N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
分子式:C22H24ClFN4O3
分子量:446.90
CAS: 184475-35-2
©2025 張家港保稅區(qū)凱利特化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問(wèn)量:14953  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |